The Nikkei Sangyo Shimbun dated February 2 introduced the joint research efforts on the diagnosis and treatment of Parkinson's disease.

Home » corporate » News » 2020 » The Nikkei Sangyo Shimbun dated February 2 introduced the joint research efforts on the diagnosis and treatment of Parkinson's disease.
2020.02.13 Media information

- -

The Nikkei Sangyo Shimbun dated February 2 introduced the joint research efforts on the diagnosis and treatment of Parkinson's disease.

On page 2020 (medical / healthcare) of the Nikkei Sangyo Shimbun dated February 2, 13, with Iwate Medical University and Takeda Pharmaceutical Company on the diagnosis and treatment of Parkinson's disease, which is an initiative of the FRONTEO Life Science AI Business Headquarters. Was introduced about the joint research of.